Health insurance in Nigeria is not widespread and does not offer comprehensive cancer care coverage. Many cancer patients have to go without necessary treatments or begin their medical treatment but must stop because they cannot afford the out-of-pocket costs associated with their cancer care. In 2020, Roche led a private-sector coalition which, with the support of the International Finance Corporation (IFC) and Nigerian public authorities, led to the creation of the Nigerian Cancer Health Fund (CHF). The CHF’s goal is to enable standard of care cancer treatment to underprivileged populations regardless of their ability to pay, and to strengthen the national cancer care ecosystem by improving quality of services. The CHF provides access to funding of up to USD 4,865 for treatments, chemotherapy, and radiation therapy services for people with breast, cervical, and prostate cancers. It is being piloted in designated centers across the country.